An Erlotinib gold (I) conjugate for combating triple-negative breast cancer
An Erlotinib triphenylphosphane gold (I) conjugate has been prepared from AuCl (PPh 3)
and its crystal structure has been established by X-ray diffraction, showing a metallo-helicate …
and its crystal structure has been established by X-ray diffraction, showing a metallo-helicate …
Erlotinib-guided self-assembled trifunctional click nanotheranostics for distinguishing druggable mutations and synergistic therapy of nonsmall cell lung cancer
Y Gao, H Zhang, Y Zhang, T Lv, L Zhang… - Molecular …, 2018 - ACS Publications
The outcome of molecular targeted therapies is restricted by the ambiguous molecular
subtypes of nonsmall cell lung cancer (NSCLC), which are difficult to be defined with …
subtypes of nonsmall cell lung cancer (NSCLC), which are difficult to be defined with …
The substituted zinc (II) phthalocyanines using “sulfur bridge” as the linkages. Synthesis, red-shifted spectroscopic properties and structure-inherent targeted …
YY Zhao, JY Chen, JQ Hu, L Zhang, AL Lin, R Wang… - Dyes and …, 2021 - Elsevier
Zinc (II) phthalocyanines are favorable candidates as photosensitizers (PSs) for
photodynamic therapy (PDT). However, zinc (II) phthalocyanines also suffer from poor water …
photodynamic therapy (PDT). However, zinc (II) phthalocyanines also suffer from poor water …
Erlotinib Pretreatment Improves Photodynamic Therapy of Non–Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms
SM Gallagher-Colombo, J Miller, KA Cengel, ME Putt… - Cancer research, 2015 - AACR
Aberrant expression of the epidermal growth factor receptor (EGFR) is a common
characteristic of many cancers, including non–small cell lung carcinoma (NSCLC), head and …
characteristic of many cancers, including non–small cell lung carcinoma (NSCLC), head and …
Photosensitizers for photodynamic therapy: Photochemistry in the service of oncology
C Lange, PJ Bednarski - Current pharmaceutical design, 2016 - ingentaconnect.com
The combined use of a photosensitizing agent, light and dioxygen for the treatment of
diseases has become known as photodynamic therapy (PDT) and was first discovered more …
diseases has become known as photodynamic therapy (PDT) and was first discovered more …
pH-responsive metallo-supramolecular nanogel for synergistic chemo-photodynamic therapy
Benefited from the high orientation of coordinated interaction, metallo-supramolecular
materials have attracted enormous interest in many fields. Herein, a novel metallo …
materials have attracted enormous interest in many fields. Herein, a novel metallo …
Phthalocyanine-biomolecule conjugated photosensitizers for targeted photodynamic therapy and imaging
Photodynamic therapy (PDT) is now in clinical practice in many European and American
countries as a minimally invasive therapeutic technique to treat oncologic malignancies and …
countries as a minimally invasive therapeutic technique to treat oncologic malignancies and …
Novel targeted photosensitizer as an immunomodulator for highly efficient therapy of T-cell acute lymphoblastic leukemia
G Yuan, M Yao, H Lv, X Jia, J Chen… - Journal of Medicinal …, 2020 - ACS Publications
Dasatinib is a kinase-targeted drug used in the treatment of leukemia. Regrettably, it
remains far from optimal medicine due to insurmountable drug resistance and side effects …
remains far from optimal medicine due to insurmountable drug resistance and side effects …
Molecular mechanisms of apoptosis and cell selectivity of zinc dithiocarbamates functionalized with hydroxyethyl substituents
In the solid state each of three binuclear zinc dithiocarbamates bearing hydroxyethyl
groups,{Zn [S 2 CN (R) CH 2 CH 2 OH] 2} 2 for R= iPr (1), CH 2 CH 2 OH (2), and Me (3) …
groups,{Zn [S 2 CN (R) CH 2 CH 2 OH] 2} 2 for R= iPr (1), CH 2 CH 2 OH (2), and Me (3) …
An advanced multifunctional prodrug combining photodynamic therapy with chemotherapy for highly efficient and precise tumor ablation
P Hu, G Xu, DC Yang, JY Liu, Z Chen, M Huang - Dyes and Pigments, 2022 - Elsevier
It is urgently required to develop the molecular agents with high therapeutic efficacy and low
side effects for precise cancer therapy. Herein, an advanced multifunctional prodrug B-BDP …
side effects for precise cancer therapy. Herein, an advanced multifunctional prodrug B-BDP …